Market Overview The U.S. small molecule CDMO market size was valued at USD 26.81 billion in 2024, growing at a CAGR of 6.4% from 2025 to 2034. The U.S. small molecule Contract Development and Manufacturing Organization (CDMO) market is experiencing significant growth due to rising demand for small molecule therapies, generic drugs, and increased focus on domestic manufacturing. The market is...